Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-22
DOI
10.3389/fcimb.2021.718213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What role for cysteamine in the defence against infection?
- (2021) Douglas Fraser-Pitt et al. Emerging Topics in Life Sciences
- Contextual Flexibility in Pseudomonas aeruginosa Central Carbon Metabolism during Growth in Single Carbon Sources
- (2020) Stephen K. Dolan et al. mBio
- Diabetic Foot Infections: Local Prevalence of and Case–Control Study of Risk Factors for Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa
- (2020) Justin J Kim et al. Open Forum Infectious Diseases
- Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
- (2020) Graham Devereux et al. PLoS One
- (R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
- (2020) Chandra L. Shrestha et al. Scientific Reports
- Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy
- (2019) Maxim Kostylev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition
- (2019) Osmel Fleitas Martínez et al. Frontiers in Cellular and Infection Microbiology
- Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation
- (2019) Ali Tahrioui et al. npj Biofilms and Microbiomes
- Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity
- (2019) Andrea Armirotti et al. Scientific Reports
- Galleria mellonella Infection Model Identifies Both High and Low Lethality of Clostridium perfringens Toxigenic Strains and Their Response to Antimicrobials
- (2019) Sammy Kay et al. Frontiers in Microbiology
- Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
- (2019) Donghoon Kang et al. Frontiers in Microbiology
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updates on the pathogenicity status of Pseudomonas aeruginosa
- (2018) Mohd W. Azam et al. DRUG DISCOVERY TODAY
- Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection
- (2018) Douglas J. Fraser-Pitt et al. INFECTION AND IMMUNITY
- RpoN-dependent direct regulation of quorum sensing and the Type VI secretion system in Pseudomonas aeruginosa PAO1
- (2018) Xiaolong Shao et al. JOURNAL OF BACTERIOLOGY
- Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
- (2018) Francesco Blasi et al. RESPIRATORY MEDICINE
- BrlR from Pseudomonas aeruginosa is a receptor for both cyclic di-GMP and pyocyanin
- (2018) Feng Wang et al. Nature Communications
- Serine Hydroxymethyltransferase ShrA (PA2444) Controls Rugose Small-Colony Variant Formation in Pseudomonas aeruginosa
- (2018) Mingming Pu et al. Frontiers in Microbiology
- A Metabolic Trade-Off Modulates Policing of Social Cheaters in Populations of Pseudomonas aeruginosa
- (2018) Huicong Yan et al. Frontiers in Microbiology
- Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages
- (2017) Chandra L. Shrestha et al. PLoS One
- Pharmacological Targeting of the Host–Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs
- (2017) Jason Munguia et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
- (2017) Eleonora Ferrari et al. Cell Death & Disease
- RpoN Promotes Pseudomonas aeruginosa Survival in the Presence of Tobramycin
- (2017) Darija Viducic et al. Frontiers in Microbiology
- Targeting the alternative sigma factor RpoN to combat virulence in Pseudomonas aeruginosa
- (2017) Megan G. Lloyd et al. Scientific Reports
- Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
- (2016) Douglas Fraser-Pitt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
- (2016) Craig Winstanley et al. TRENDS IN MICROBIOLOGY
- GcsR, a TyrR-Like Enhancer-Binding Protein, Regulates Expression of the Glycine Cleavage System in Pseudomonas aeruginosa PAO1
- (2016) Zaara Sarwar et al. mSphere
- Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains
- (2015) Louise Cullen et al. MICROBIOLOGY-SGM
- Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
- (2015) Graham Devereux et al. EBioMedicine
- Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
- (2014) Daniela De Stefano et al. Autophagy
- Cyclic-di-GMP levels affectPseudomonas aeruginosafitness in the presence of imipenem
- (2014) Gianlucca G. Nicastro et al. ENVIRONMENTAL MICROBIOLOGY
- Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
- (2014) Cedric Charrier et al. Orphanet Journal of Rare Diseases
- Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
- (2014) Dilip Nathwani et al. Antimicrobial Resistance and Infection Control
- Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry
- (2013) E. Kerem et al. EUROPEAN RESPIRATORY JOURNAL
- Gene PA2449 Is Essential for Glycine Metabolism and Pyocyanin Biosynthesis in Pseudomonas aeruginosa PAO1
- (2013) B. R. Lundgren et al. JOURNAL OF BACTERIOLOGY
- Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and withoutPseudomonas aeruginosainfection
- (2013) Francis J Gilchrist et al. Journal of Breath Research
- Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability
- (2012) Julien M. Buyck et al. CLINICAL INFECTIOUS DISEASES
- Pseudomonas aeruginosaPopulation Diversity and Turnover in Cystic Fibrosis Chronic Infections
- (2011) Eilidh Mowat et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture
- (2011) Aamir Ghafoor et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Galleria mellonella as an infection model for Campylobacter jejuni virulence
- (2011) N. J. Senior et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Exploratory Study of the Prevalence and Clinical Significance of Tobramycin-Mediated Biofilm Induction in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
- (2010) D. Elliott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units
- (2010) Despoina Koulenti et al. CRITICAL CARE MEDICINE
- Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
- (2010) Michael W. Konstan et al. Journal of Cystic Fibrosis
- Performance of five different electrospray ionisation sources in conjunction with rapid monolithic column liquid chromatography and fast MS/MS scanning
- (2009) Karl E. V. Burgess et al. PROTEOMICS
- Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients
- (2008) B. Ryall et al. EUROPEAN RESPIRATORY JOURNAL
- Membrane topology and roles of Pseudomonas aeruginosa Alg8 and Alg44 in alginate polymerization
- (2008) L. L. Oglesby et al. MICROBIOLOGY-SGM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search